Title

Summary

Novel developments in atrial fibrillation - First closed-chest, robotic procedure

Dr Allen R Raczkowski, a cardiothoracic surgeon at Banner Baywood Heart Hospital in Mesa, Arizon...[more]

Apprehension still exists over DES safety

Significant concerns regarding the risk of late stent thrombosis and the use of drug-eluting ste...[more]

FDA panel recommends against ‘off-label’ use

The Circulatory System Devices Advisory Panel of the FDA has deiced that larger and longer pre-m...[more]

UK review recommends limited use of VADs

An evaluation by the Health Technology Assessment (HTA) programme, part of the National Institut...[more]

Call for larger studies following successful REPAIR-AMI LATE trial

The latest results from the REPAIR-AMI LATE trial has found that patients who were treated with ...[more]

Carotid pacemaker can reduce hypertension

Hypertension is estimated to cause one in every eight deaths in the world and is also associated...[more]

Tryton Medical completes study enrolment

Tryton Medical completed the enrolment phase of the Tryton First-in-Man (FIM) Study. The multi-c...[more]

Paracor Medical - minimally-invasive devices for the treatment of heart failure

Paracor Medical is a development stage medical device company focused on providing mechanical me...[more]

New technological developments in laparoscopic surgery and graft infection

Dr Yves S Alimi, Head of the Department of Vascular Surgery at the Centre Hospitalo-Universitair...[more]

First patients treated with new SurgiFrost XL

The first patients have been treated with SurgiFrost XL, a new minimally invasive surgical probe...[more]

New device broadens company’s thrombus management productline

Possis Medical has received marketing approval for its new AngioJet Ultra Thrombectomy System. U...[more]

Mixed news for Boston/Angiotech in patent battle against Conor

There has been two different verdicts announced in the UK and The Netherlands and concerning sev...[more]

CryoLife signs development and distribution agreements

CryoLife has signed an agreement with the Cleveland Clinic to develop an innovative allograft he...[more]

MIV Therapeutics completes US$4 million financings

MIV Therapeutics (MIVT) has announced two recent financings totalling US$4 million to accelerate...[more]

Boston Scientific to reallocate CRM R&D resources

Boston Scientific plans to reallocate its cardiac rhythm management (CRM) research and developme...[more]

First human implant of Sorin’s Percutaneous Heart Valve Project

Sorin has announced the first successful implant of its first uniquely-designed heart valve suit...[more]

Valecor Coronary Stent System receives European approval

CorNova’s wholly- owned German subsidiary CorNova GmbH, has received the CE mark for its Valecor...[more]

Medtronic receives approval for Transcatheter heart valve system

Medtronic has received a Medical Device License from Health Canada to sell its Melody Transcathe...[more]